SCHEMBL1782313

SCHEMBL1782313

Cc1cc(-c2ccc(NC(=O)Nc3ccc4ncccc4c3)cc2)ccn1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.69
POLB P06746 3/20 0.69
MAPT P10636 2/20 0.69
MEN1 O00255 1/20 0.69
KMT2A Q03164 1/20 0.69
PSEN1 P49768 6/20 0.58
PSEN2 P49810 6/20 0.58
APH1B Q8WW43 6/20 0.58
NCSTN Q92542 6/20 0.58
APH1A Q96BI3 6/20 0.58
PSENEN Q9NZ42 6/20 0.58
NAMPT P43490 1/20 0.58
RAB9A P51151 2/20 0.55
MMP9 P14780 1/20 0.53
PABPC1 P11940 1/20 0.52
PORCN Q9H237 3/20 0.52
WNT3A P56704 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.51
GSK3B P49841 1/20 0.50
NOTUM Q6P988 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492672 0.85 PSEN1 (0.53) NPC1POLBMAPTMEN1KMT2A
SCHEMBL7964847 0.85 PSEN1 (0.53) NPC1POLBMAPTMEN1KMT2A
SCHEMBL5661569 0.85 NPC1 (0.81) NPC1POLBMAPTMEN1KMT2A
SCHEMBL1492673 0.84 WNT3A (0.52) NPC1POLBMAPTMEN1KMT2A
SCHEMBL31054249 0.83 NPC1 (1.00) NPC1POLBMAPTMEN1KMT2A
SCHEMBL651929 0.83 NPC1 (1.00) NPC1POLBMAPTMEN1KMT2A
SCHEMBL1493028 0.82 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2184573 0.82 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5658310 0.81 NPC1 (0.88) NPC1POLBMAPTMEN1KMT2A
SCHEMBL1492870 0.80 PSEN1 (0.67) KMT2APSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 NPC1 569/4885POLB 745/4885MAPT 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.